Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 03-2023 | 01-2023 | 12-2022 | 10-2022 | 09-2022 | |
| Operating Expenses | 1,767 | 4,633 | 0 | 492 | 523 |
| Operating Income | -1,767 | -4,633 | N/A | -492 | -523 |
| Interest Expense | 0 | 1,175 | 0 | 0 | 0 |
| Other Income | 1,415 | -1,610 | 0 | 1,112 | 596 |
| Pre-tax Income | -352 | -7,418 | 0 | 620 | 73 |
| Net Income Continuous | -352 | -7,418 | N/A | 620 | 73 |
| Net Income | $-352 | $-7,418 | $N/A | $620 | $73 |
| EPS Basic Total Ops | -0.02 | -13.29 | 0.05 | -44.25 | 0.00 |
| EPS Basic Continuous Ops | -0.11 | -11.39 | 0.20 | -37.15 | 0.02 |
| EPS Diluted Total Ops | -0.02 | -13.29 | 0.05 | -44.25 | 0.00 |
| EPS Diluted Continuous Ops | -0.11 | -11.39 | 0.20 | -37.15 | 0.02 |
| EBITDA(a) | $-1,767 | $-4,587 | $N/A | $-254 | $-523 |